Molecular mechanism of endosomal sorting of growth factors and receptors
生长因子和受体内体分选的分子机制
基本信息
- 批准号:15370053
- 负责人:
- 金额:$ 9.79万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Upon stimulation with growth factors, their receptors are rapidly internalized as a complex with bound ligands, and are transported to the endosome. From the endosome, ligand-bound receptors are transported to the lysosome for degradation. In this study, we examined the molecular mechanisms how Hrs and STAM regulate the endosomal sorting of growth factor/receptor complexes, and obtained the following results.1.STAM mutants lacking the Hrs-binding activity were defective in causing the enlargement of early endosomes, accumulating ubiquitinated proteins on this aberrant organelle, and inhibiting the degradation of ligand-activated epidermal growth factor receptors(EGFR). These results indicate that association with Hrs on the early endosome is a prerequisite for STAM function.2.Overexpression of a deubiquitinating enzyme UBPY that is a STAM binding protein, reduced the ubiquitination level of EGFR and delayed its degradation in EGF-stimulated cells. In contrast overexpression of a catalytically-inactive UBPY mutant did not show such effects. These results indicate that UBPY plays an important role through reduction of the ubiquitination level of EGFR in regulation of EGFR sorting.3.ALG-2 was identified as a novel Hrs-binding protein by a yeast two-hybrid screening. Hrs, ALG-2 and an ALG-2 binding protein Alix were bound in a Ca^<2+>-dependent manner. Treatment of cells with a Ca^<2+> ionophore induced colocalization of these proteins to the early endosome. These results suggest that Hrs regulates endosomal sorting by recruiting Alix through ALG-2 to the early endosome in a Ca^<2+>-dependent manner.
在生长因子刺激后,它们的受体迅速内化为与结合配体的复合物,并被转运至内体。配体结合受体从内体转运至溶酶体进行降解。本研究探讨了Hrs和STAM调节生长因子/受体复合物内体分选的分子机制,得到了以下结果:1.缺乏Hrs结合活性的STAM突变体无法引起早期内体的增大,在异常细胞器上积累泛素化蛋白,并抑制配体激活的降解。 表皮生长因子受体(EGFR)。这些结果表明,早期内体上Hrs的结合是STAM功能的先决条件。2.STAM结合蛋白去泛素化酶UBPY的过度表达,降低了EGFR的泛素化水平,延缓了EGF刺激细胞的降解。相反,催化失活的 UBPY 突变体的过度表达没有显示出这样的效果。这些结果表明UBPY通过降低EGFR的泛素化水平在EGFR分选的调控中发挥重要作用。3.酵母双杂交筛选将ALG-2鉴定为一种新型的Hrs结合蛋白。小时,ALG-2和ALG-2结合蛋白Alix以Ca 2+ 依赖性方式结合。用Ca 2+ 离子载体处理细胞诱导这些蛋白质共定位至早期内体。这些结果表明,Hrs通过ALG-2以Ca 2+ 依赖性方式将Alix募集到早期内体来调节内体分选。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Nakano: "Cofilin phosphorylation and actin polymerization by NRK/NESK, a member of the germinal center kinase family"Exp.Cell Res.. 287. 219-227 (2003)
K.Nakano:“生发中心激酶家族成员 NRK/NESK 的肌动蛋白丝切蛋白磷酸化和肌动蛋白聚合”Exp.Cell Res.. 287. 219-227 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue
- DOI:10.1111/j.1349-7006.2004.tb02185.x
- 发表时间:2004-10-01
- 期刊:
- 影响因子:5.7
- 作者:Inoue, T;Kataoka, H;Miyazawa, K
- 通讯作者:Miyazawa, K
A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1
- DOI:10.1074/jbc.m212160200
- 发表时间:2003-06-20
- 期刊:
- 影响因子:4.8
- 作者:Inomata, H;Nakamura, Y;Kitamura, N
- 通讯作者:Kitamura, N
STAM protein bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif
STAM 蛋白通过 VHS 结构域和泛素相互作用基序结合早期内涵体上的泛素化蛋白
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Matsumoto;M.;Yada;M.;Hatakeyama;S.;Ishimoto;H.;Tanimura;T.;Tsuji;S.;Kakizuka;A.;Kitagawa;M.;Nakayama;K.I.;E.Mizuno
- 通讯作者:E.Mizuno
Involvement of down regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2
Cdk2活性下调参与肝细胞生长因子诱导的人肝癌细胞系HepG2细胞周期阻滞在G1期
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kano;F.;山内忍;村田昌之;Fumi Kano;Fumi Kano;Satomi Nadanaka;J.Ichinose;加納ふみ;加納ふみ;田中亜路;M.Nakamura;M.Komada;H.Kakinuma;H.Tanaka;J.Han;E.Mizuno;T.Hori;E.Mizuno;C.Morino;H.Itoh;T.Inoue;Y.Tsukada
- 通讯作者:Y.Tsukada
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KITAMURA Naomi其他文献
KITAMURA Naomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KITAMURA Naomi', 18)}}的其他基金
Regulation of the endosomal sorting and intracellular signaling ofgrowth factor receptors
生长因子受体内体分选和细胞内信号传导的调节
- 批准号:
19370050 - 财政年份:2007
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of regulation of growth factor receptor sorting at endosomes
内体生长因子受体分选调节的分子机制
- 批准号:
17370045 - 财政年份:2005
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of the regulatory mechanism of endocytosis of growth factors and receptors
生长因子和受体内吞调节机制的表征
- 批准号:
13480235 - 财政年份:2001
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of hepatocyte growth factor activator inhibitors which are being developed for a medicine
正在开发的药物肝细胞生长因子激活剂抑制剂的表征
- 批准号:
13557012 - 财政年份:2001
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of novel regulators of vesicular transport in endocytosis and exocytosis
胞吞作用和胞吐作用中囊泡运输的新型调节剂的功能表征
- 批准号:
11480206 - 财政年份:1999
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
- 批准号:
10557017 - 财政年份:1998
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
- 批准号:
09480161 - 财政年份:1997
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of a novel tyrosine phosphorylated protein in signal transduction of hepatocyte growth factor
新型酪氨酸磷酸化蛋白在肝细胞生长因子信号转导中的功能表征
- 批准号:
07458164 - 财政年份:1995
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structural and functional characterization of a novel serine protease responsible for activation of hepatocyte growth factor
负责肝细胞生长因子激活的新型丝氨酸蛋白酶的结构和功能表征
- 批准号:
05454625 - 财政年份:1993
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Functional analysis of domain structures of human hepatocyte growth factor
人肝细胞生长因子结构域的功能分析
- 批准号:
02454540 - 财政年份:1990
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Treatment of periodontitis by epidermal growth factor receptor inhibitor
表皮生长因子受体抑制剂治疗牙周炎
- 批准号:
479002 - 财政年份:2023
- 资助金额:
$ 9.79万 - 项目类别:
Operating Grants
Role of a craniosynostosis associated fibroblast growth factor receptor mutation in extraocular muscles
颅缝早闭相关成纤维细胞生长因子受体突变在眼外肌中的作用
- 批准号:
10644569 - 财政年份:2023
- 资助金额:
$ 9.79万 - 项目类别:
A Tissue-Specific Soluble Platelet-Derived Growth Factor Receptor-beta Isoform Retains Functional Capacity
组织特异性可溶性血小板衍生生长因子受体-β亚型保留功能能力
- 批准号:
10668031 - 财政年份:2023
- 资助金额:
$ 9.79万 - 项目类别:
The chaperone cycle of fibroblast growth factor receptor kinases in molecular detail
成纤维细胞生长因子受体激酶的分子伴侣循环的分子细节
- 批准号:
BB/W008017/1 - 财政年份:2022
- 资助金额:
$ 9.79万 - 项目类别:
Research Grant
Measurement of epidermal growth factor receptor transport dynamics in cells using imaging fluorescen
使用荧光成像测量细胞中表皮生长因子受体转运动力学
- 批准号:
573571-2022 - 财政年份:2022
- 资助金额:
$ 9.79万 - 项目类别:
University Undergraduate Student Research Awards
Treatment of periodontitis by epidermal growth factor receptor inhibitor
表皮生长因子受体抑制剂治疗牙周炎
- 批准号:
477322 - 财政年份:2022
- 资助金额:
$ 9.79万 - 项目类别:
Operating Grants
Development of Predictive Markers for Sensitivity to Fibroblast Growth Factor Receptor Inhibitors Using Colorectal Cancer Stem Cells
使用结直肠癌干细胞开发成纤维细胞生长因子受体抑制剂敏感性的预测标记
- 批准号:
21K20818 - 财政年份:2021
- 资助金额:
$ 9.79万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease
纤维化皮肤病中的表皮生长因子受体信号传导
- 批准号:
10653037 - 财政年份:2021
- 资助金额:
$ 9.79万 - 项目类别:
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease
纤维化皮肤病中的表皮生长因子受体信号传导
- 批准号:
10214929 - 财政年份:2021
- 资助金额:
$ 9.79万 - 项目类别:
An Investigation to Identify Risk Factors for the Development of Acneiform Eruptions in Patients on Epidermal Growth Factor Receptor Inhibitors
一项旨在确定使用表皮生长因子受体抑制剂的患者发生痤疮样皮疹的危险因素的调查
- 批准号:
466972 - 财政年份:2021
- 资助金额:
$ 9.79万 - 项目类别:
Studentship Programs














{{item.name}}会员




